T. Rowe Price Associates »

Silence Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.2M 229k 18.18

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Tesla Comm Stk (TSLA)
Broadcom Comm Stk (AVGO)
Unitedhealth Group Comm Stk (UNH)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Morgan Stanley
Frazier Life Sciences Management
Vivo Capital
Nantahala Capital Management
Polar Capital Holdings
Deep Track Capital
Nextech Invest
Eventide Asset Management
Point72 Asset Management
Bank of America Corporation
Woodline Partners

View all funds holding Silence Therapeutics